Emerging data suggest Retatrutide , a dual stimulator targeting both the gut-brain axis and glucose-dependent insulinotropic polypeptide , could offer a promising step forward for body management . Initial human investigations have shown substantial decreases in body mass , potentially surpassing existing obesity treatments. However , more evaluati